An interventional study of Electroacupuncture and Standard Therapy in Oligozoospermia, Oligoasthenozoospermia and Oligoasthenoteratozoospermia, sponsored by Indonesia University. Completed at 1 site in Indonesia. Open to male participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-12-28.
Sponsored by Indonesia University · Not applicable, Interventional, and Supportive care
The goal of this clinical trial is to compare in Oligozoospermia Patient. The main questions it aims to answer are: 1. Electroacupuncture therapy and standard therapy can affect oligozoospermia. 2. Electroacupuncture therapy and standard therapy can affect semen and spermatozoa plasma SOD levels.
Researchers will compare patient with standard therapy with patient with standard therapy with electroacupuncture.
64 studies on the registry are indexed under Oligospermia; 17 are open to participants now.
This study's enrollment of 48 is below the median of 65 across 46 interventional studies indexed under Oligospermia.
Browse Oligospermia studies →Indonesia University is the lead sponsor of 446 studies on the registry; 56 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients diagnosed with Oligozoospermia who only receive standard therapy from an Andrologist as a standard therapy.
Patients diagnosed with Oligozoospermia receive standard therapy from an Andrologist and Electroacupuncture.
Other: Electroacupuncture and Standard Therapy
Acupuncture Needle Insertion with Electroacupuncture machine.
Sperm analysis
Spermatozoa/mL
Time frame: Before Treatment in day 1, After 30 days of treatment.
SOD Spermatozoa
Superokside Dismutase in Spermatozoa
Time frame: Before Treatment in day 1, After 30 days of treatment.
SOD Plasma Semen
Superokside Dismutase in Plasma Semen
Time frame: Before Treatment in day 1, After 30 days of treatment.
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2023 to primary completion in Nov 2023, 2 months.
Of 16 interventional studies with no phase under Oligospermia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 36. This study's 2 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.